Loading
Latest filing published 18 Jun 2026 for RemeGen Co., Ltd. - H Shares. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Lin Jian is a declared insider at 2 companies (chief executive); the most frequent names are RemeGen Co., Ltd. and RemeGen Co., Ltd. - H Shares. The record holds 19 filings, for trades running from 29 September 2025 to 16 June 2026.
Market trades split into 5 purchases and 11 sales (€7.4M). The totals do not cover 7 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2026 to date brings 5 purchases and 11 sales.
No cluster: in 5 purchases, no other insider of the company bought within 30 days.
The latest filing, published on 18 June 2026, reports a transaction in RemeGen Co., Ltd. - H Shares. The latest purchase dates back some time: it was published 125 days ago, on 15 June 2026. The median gap between a trade and its publication by HKEX is 6 days. The shorter that gap, the sooner other investors can see what insiders have done. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from HKEX. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 10 declarations